Literature DB >> 15928468

The detrimental effects of ventilation during low-blood-flow states.

Paul E Pepe1, Lynn P Roppolo, Raymond L Fowler.   

Abstract

PURPOSE OF REVIEW: In recent years, it has become increasingly apparent that resuscitative ventilatory procedures, classically thought to be life saving, may have profound detrimental effects. RECENT
FINDINGS: Most assisted breathing techniques during resuscitation involve the provision of intermittent positive pressure ventilation to inflate lung zones for erythrocyte oxygenation and clearance of carbon dioxide. A growing number of studies involving low-flow states, however, have demonstrated that provision of overzealous (or even 'normal') ventilatory rates with intermittent positive pressure ventilation can significantly diminish both systemic and coronary circulation, most likely through inhibition of venous return. Recent laboratory studies of hemorrhage have shown not only a direct detrimental impact of each positive pressure ventilation breath on coronary perfusion, but also how dramatic improvements in blood flow can be achieved, without loss of oxygenation, by delivering breaths infrequently during such low-flow states. Likewise, in cardiac arrest models, studies have shown that interrupting chest compressions, even to provide breaths, can be extremely deleterious by abruptly (and continually) lowering the aortic pressure head to the coronary arteries, thus impairing restoration of spontaneous circulation. Even with endotracheal intubation and uninterrupted chest compressions, frequent positive pressure ventilation still inhibits circulation during cardiopulmonary resuscitation. Despite directed training, paramedics (and other rescuers) have been shown to still excessively ventilate during cardiac arrest resuscitations.
SUMMARY: Ventilation can have profound detrimental hemodynamic effects in low-flow states, exacerbating the circulatory compromise. This underappreciated confounding variable may be one of the reasons many clinical trials of resuscitative interventions have failed despite dramatic successes in the laboratory.

Entities:  

Mesh:

Year:  2005        PMID: 15928468     DOI: 10.1097/01.ccx.0000163650.80601.24

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  5 in total

1.  Complications of endotracheal intubation in the critically ill.

Authors:  Donald E G Griesdale; T Laine Bosma; Tobias Kurth; George Isac; Dean R Chittock
Journal:  Intensive Care Med       Date:  2008-07-05       Impact factor: 17.440

2.  Prolonged emergency department length of stay is not associated with worse outcomes in patients with intracerebral hemorrhage.

Authors:  Jonathan Elmer; Daniel J Pallin; Shan Liu; Catherine Pearson; Yuchiao Chang; Carlos A Camargo; Steven M Greenberg; Jonathan Rosand; Joshua N Goldstein
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

3.  [Comments on the 2010 guidelines on cardiopulmonary resuscitation of the European Resuscitation Council].

Authors:  V Wenzel; S G Russo; H R Arntz; J Bahr; M A Baubin; B W Böttiger; B Dirks; U Kreimeier; M Fries; C Eich
Journal:  Anaesthesist       Date:  2010-12       Impact factor: 1.041

4.  Evaluation of the impact of implementing the emergency medical services traumatic brain injury guidelines in Arizona: the Excellence in Prehospital Injury Care (EPIC) study methodology.

Authors:  Daniel W Spaite; Bentley J Bobrow; Uwe Stolz; Duane Sherrill; Vatsal Chikani; Bruce Barnhart; Michael Sotelo; Joshua B Gaither; Chad Viscusi; P David Adelson; Kurt R Denninghoff
Journal:  Acad Emerg Med       Date:  2014-08-11       Impact factor: 3.451

Review 5.  [Cardiac arrest under special circumstances].

Authors:  Carsten Lott; Anatolij Truhlář; Anette Alfonzo; Alessandro Barelli; Violeta González-Salvado; Jochen Hinkelbein; Jerry P Nolan; Peter Paal; Gavin D Perkins; Karl-Christian Thies; Joyce Yeung; David A Zideman; Jasmeet Soar
Journal:  Notf Rett Med       Date:  2021-06-10       Impact factor: 0.826

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.